Private Market View

Elixirgen Therapeutics

Baltimore, MD · Founded 2012 · Privately Held (backing)

Last price · $/share
Implied valuation
$67.0M
Total raised
$29.1M
Last round
Seed Round
Oct 2025
What is Elixirgen Therapeutics worth?
$67.0Mlast known valuation

Elixirgen Therapeutics last raised $4.0M in its Seed Round (Oct 2025).

Free account
See the evidence behind this price
  • ·Post-money valuations for all 8 rounds
  • ·The complete investor list — 2 names
  • ·Watchlist + deal alerts for Elixirgen Therapeutics
Create free account
No card required

Funding history

8 rounds
DateRoundRaisedPost-money
Oct 2025Seed Round$4.0M
Mar 2025Seed Round$3.6M
Jan 2025Seed Round$600K
Nov 2023Early Stage VC$7.0M
Sep 2022Debt$5.0M
Feb 2021Seed Round$4.2M
+ 2 earlier rounds · a free account shows the full history

How Elixirgen Therapeutics's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Elixirgen Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked

What is Elixirgen Therapeutics worth?
Elixirgen Therapeutics's last known valuation is $67.0M.
How much has Elixirgen Therapeutics raised?
Elixirgen Therapeutics has raised $29.1M in total funding across 8 recorded rounds.
When did Elixirgen Therapeutics last raise?
Elixirgen Therapeutics last raised in Oct 2025 (Seed Round), raising $4.0M.